HAMMOND, LA – Owners Don Fellows, RPh, and daughter Hayley Taff of Central Rexall Drugs, Inc. in Hammond joined a nationwide effort to preserve patient access to compounded medications as part of the International Academy of Compounding Pharmacists (IACP) 2016 Compounders on Capitol Hill (CCH) 22nd annual conference and legislative event, held June 11-14, 2016 in Washington, D.C.
Fellows and more than 300 community pharmacists, pharmacy technicians and pharmacy students traveled to Washington to meet with their lawmakers and hear from Congressmen Buddy Carter (R-GA), Doug Collins (R-GA) and Chris Stewart (R-UT). The compounding representatives discussed preserving patient access to customized medications, and challenges with the Food & Drug Administration’s (FDA) implementation of the federal Drug Quality and Security Act (DQSA).
Don Fellows, RPh, at Compounders on Capitol Hill 2016
Fellows and Taff met with many lawmakers at the Compounders on Capitol Hill event
“This trip provided the opportunity to speak directly to members of Congress and voice concerns on behalf of our practitioners and their patients, whose access to pharmacy compounds directly impacts their health care,” said Hayley Taff. “Some of our profession’s most active pharmacists gathered in our nation’s capital to take the voice of compounding to the Hill.”
IACP continues to educate patients, prescribers, pharmacists, patient advocacy groups, congressional offices, regulatory agencies, state pharmacy associations and state pharmacy boards about the vital importance of continued access to compounded medications.
“Our IACP Members’ visits with Congress occurred at a particularly important time for compounding pharmacies across the country and for the patients whom they serve,” says IACP Executive Vice President John Voliva, RPh. “We believe it’s vital that patients and practitioners continue to have access to compounded medications prepared by licensed pharmacists who are following the necessary guidelines and who are helping patients and practitioners with personalized medication solutions each and every day. We are working closely with our Hill representation, federal regulatory agencies, and state boards of pharmacy to ensure that DQSA is enacted as it was intended by Congress.”
About Central Rexall Drugs
For over 120 years, Central Rexall Drugs has specialized in compounded medications to fit individuals’ specific health needs. Central is recognized as a leader in medication compounding and has the core focus of providing outstanding patient service and the best medications to their patients. Central Rexall Drugs is a PCAB® Accredited compounding pharmacy, a designation earned by only the top pharmacies nationwide. Central is also a proud members of the United Compounding Management High Performance Network (UCM), the Professional Compounding Centers of America (PCCA), and the International Academy of Compounding Pharmacists (IACP).
For more information about Central Rexall Drugs, contact us.
The International Academy of Compounding Pharmacists (IACP) is an association representing more than 4,000 pharmacists, technicians, students, and members of the compounding community who focus upon the specialty practice of pharmacy compounding. Compounding pharmacists work directly with prescribers including physicians and nurse practitioners to create customized medication solutions for patients whose healthcare needs cannot be met by manufactured medications. IACP’s mission of protecting, promoting and advancing personalized medication solutions is critical for patient healthcare.
IACP VP Communications